NEW YORK (GenomeWeb News) – BioFire Diagnostics today said that Athyrium Opportunities Fund increased its investment in the company to $45 million.

Athyrium invested $25 million into BioFire in September. The new financing will go toward continued commercialization of and to meet growing demand for the Salt Lake City-based company's FilmArray molecular diagnostic platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.